| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-09 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-09 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.24 | 1e-06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |